National
Perkins advises parents not to ‘condone and enable’ homosexuality
Anti-gay leader compares homosexuality to drug use
Family Research Council Tony Perkins speaks before a National Press Club luncheon (Blade photo by Michael Key)
A prominent social conservative leader compared homosexuality to drug use on Wednesday while urging parents not to “condone and enable” a child being gay.
Tony Perkins, president of the anti-gay Family Research Council, made the remarks while speaking at the National Press Club luncheon after being asked if he would disown one of his children if they came out as gay.
Perkins, the father of five children, replied that he wouldn’t “disown my children for anything,” but advised parents they should express disapproval if their children make such an announcement.
“And if we really love them, we’ll be willing to tell them the truth that the choices that they have made, continuing what they’re doing, are both destructive to them personally and society as a whole,” Perkins said. “And so while I would disagree with my child getting involved in that lifestyle, I would not in any way — nor would I ever encourage a parent — to disown a child because of something like that that occurs. Love them compassionately, pray for them, but don’t condone and enable that behavior, whatever it might be.”
Perkins said as a parent he has “a responsibility for the environment in which I raise my children,” suggesting that sexual orientation is determined by parenting — a notion disputed by major psychiatric groups. Later in his comments, Perkins compared homosexuality to drug use.
“I believe as a parent we have the ability to protect them from a lot of unfortunate experiences that have shaping influences upon their lives,” Perkins said. “That’s not to say that those whose children may have ended up in homosexuality were not good parents. We can’t guarantee that. We can do our very best job as a parent and still something may happen, whether they end up in drugs or whether they end up in some other lifestyle that they end up.”
At the beginning of his response, Perkins said similar inquiries has been posed to him previously on national TV as what he called a “gotcha” question. The inquiry on Wednesday came from National Press Club President Theresa Werner, who was reading questions submitted in advance by reporters and attendees at the event.
Michael Cole-Schwartz, an HRC spokesperson, responded by saying Perkins is spreading lies about LGBT people and that parents should provide “unconditional support” to children who come out.
“Tony Perkins continues to spread lies and misinformation and his comments are offensive to the millions of LGBT people and those who love and respect us,” Cole-Schwartz said. “LGBT young people need unconditional support, not leaders or parents who will compare their inherent identities to things like substance abuse. It’s time Tony Perkins disavows that junk science and learns what the experts have to say about sexual orientation and gender identity.”
In response to another question submitted by the Washington Blade, Perkins said he thinks the Republican presidential nominee Mitt Romney is getting better about talking about views of marriage and gay rights favorable to social conservatives. Perkins gave general praise to Romney, despite grumblings throughout his campaign from social conservatives who’ve said they suspect the candidate doesn’t share their views.
“I think Mitt Romney is doing a good job in becoming more comfortable in talking about the issues of faith, talking about the social issues of marriage, and life in particular,” Perkins said. “There is no question that we have theological differences when it comes to our religions, but we have a shared concern over where this country is headed today. And we have a shared value system that we believe can put American on the right way. I believe that Gov. Romney is doing a good job in reaching out and bringing in all concerns within the conservative movement, including those of social conservatives.”
A substantial portion of Perkins’ prepared remarks was devoted to following up on a shooting at the Family Research Council’s D.C. headquarters in which a guard, Leo Johnson, was wounded and the accused assailant was a volunteer for the D.C. Center for the LGBT Community. In addition to ammunition and guns, the assailant was carrying a backpack filled with sandwiches from Chick-fil-A, which had been under scrutiny for the anti-gay views of its owners.
In the wake of the shooting, Perkins said the mission of his organization to advocate social conservative values remains unchanged.
“As I said here today, I pledge to redouble our efforts to persuade our fellow citizens on these issues and to move the electorate to embrace the core principles a majority of this nation have long espoused,” Perkins said. “But I also pledge to redouble our efforts to advocate these ideas with civility and compassion. … Our aim is to speak the truth in love, and if we fail to do so, we will acknowledge it, and we will set the record straight, and that includes what we say regarding homosexuality. And I would hope the other side would make a similar commitment.”
Perkins accused organizations like the Southern Poverty Law Center, which has labeled the Family Research Council a hate group, of fostering “an environment of hostility” that encourage incidents like the shooting to take place. Perkins said he’s renewing the call on Southern Poverty Law Center and the Human Rights Campaign to stop its characterization of the Family Research Council as a hate group.
“It is time for the vindictiveness to end, and I say with confidence to SPLC and HRC, it’s time to dial down the demonization of those who differ with you,” Perkins said. “It’s time to start hurling labels of hate and have a legitimate debate about policies that govern our nation.”
Cole-Schwartz responded to the accusations against HRC by saying his organization want civil discussion, but criticized the Family Research Council for its statements about LGBT people.
“HRC welcomes reasoned debate over public policy but that must be predicated on truth, not wholesale denigration of LGBT people and our families,” Cole-Schwartz said. “When the FRC is ready to give up on their hateful lies, we’ll be ready to stop calling them out for it.”
Asked whether during the question-and-answer portion if the suspected shooter should be charged with a hate crime, a kind of law that the Family Research Council opposes, Perkins said he’d leave that decision to law enforcement, but noted the FBI is investigating it as an act of domestic terrorism. Perkins added on the day of shooting, employees at his organization prayed for the alleged perpetrator as well as other involved.
“We pray for him, we pray for his spiritual well-being, but I will echo, once again, we will not allow these types of threats or acts of violence in any way to deter us from standing for the things that we represent here in Washington,” Perkins said.
State ballot measures related to marriage also came up during the event. During his prepared remarks, Perkins noted that 7 of the 9 states identified as swing states in the presidential election have approved constitutional amendments banning same-sex marriage. He also predicted anti-gay forces would have a favorable outcome in the four states where marriage is coming up on the ballot: Minnesota, Maryland, Washington State and Maine.
Perkins spoke before attendees at the National Press Club prior the 2012 Values Voter Summit, a three-day national event held that will be this week in D.C. for social conservatives. Among the high-profile speakers scheduled at the event are Republican vice presidential nominee Paul Ryan, House Majority Leader Eric Cantor (R-Va.) and former U.S. Sen. Rick Santorum. LGBT groups including the Human Rights Campaign and other organizations sent a joint letter to public these officials asking them not to participate in the event, although none have cancelled their participation as a result.
Among Perkins’ guests alongside him at the table near the podium were Bishop Harry Jackson of Hope Christian Church, a leader in the fight against Maryland’s same-sex marriage law, and anti-gay Rep. Louie Gohmert (R-Texas.)
A Wider Bridge on Friday announced it will shut down at the end of the month.
The group that “mobilizes the LGBTQ community to fight antisemitism and support Israel and its LGBTQ community” in a letter to supporters said financial challenges prompted the decision.
“After 15 years of building bridges between LGBTQ communities in North America and Israel, A Wider Bridge has made the difficult decision to wind down operations as of Dec. 31, 2025,” it reads.
“This decision comes after challenging financial realities despite our best efforts to secure sustainable funding. We deeply appreciate our supporters and partners who made this work possible.”
Arthur Slepian founded A Wider Bridge in 2010.
The organization in 2016 organized a reception at the National LGBTQ Task Force’s Creating Change Conference in Chicago that was to have featured to Israeli activists. More than 200 people who protested against A Wider Bridge forced the event’s cancellation.
A Wider Bridge in 2024 urged the Capital Pride Alliance and other Pride organizers to ensure Jewish people can safely participate in their events in response to an increase in antisemitic attacks after Hamas militants attacked Israel on Oct. 7, 2023.
The Jewish Telegraphic Agency reported authorities in Vermont late last year charged Ethan Felson, who was A Wider Bridge’s then-executive director, with lewd and lascivious conduct after alleged sexual misconduct against a museum employee. Rabbi Denise Eger succeeded Felson as A Wider Bridge’s interim executive director.
A Wider Bridge in June honored U.S. Rep. Debbie Wasserman Schultz (D-Fla.) at its Pride event that took place at the Capital Jewish Museum in D.C. The event took place 15 days after a gunman killed two Israeli Embassy employees — Yaron Lischinsky and Sarah Milgrim — as they were leaving an event at the museum.
“Though we are winding down, this is not a time to back down. We recognize the deep importance of our mission and work amid attacks on Jewish people and LGBTQ people – and LGBTQ Jews at the intersection,” said A Wider Bridge in its letter. “Our board members remain committed to showing up in their individual capacities to represent queer Jews across diverse spaces — and we know our partners and supporters will continue to do the same.”
Editor’s note: Washington Blade International News Editor Michael K. Lavers traveled to Israel and Palestine with A Wider Bridge in 2016.
The White House
‘Trump Rx’ plan includes sharp cuts to HIV drug prices
President made announcement on Friday
President Donald Trump met with leaders from some of the world’s largest pharmaceutical companies at the White House on Friday to announce his new “Trump Rx” plan and outline efforts to reduce medication costs for Americans.
During the roughly 47-minute meeting in the Roosevelt Room, Trump detailed his administration’s efforts to cut prescription drug prices and make medications more affordable for U.S. patients.
“Starting next year, American drug prices will come down fast, furious, and will soon be among the lowest in the developed world,” Trump said during the meeting. “For decades, Americans have been forced to pay the highest prices in the world for prescription drugs by far … We will get the lowest price of anyone in the world.”
Trump signed an executive order in May directing his administration “to do everything in its power to slash prescription drug prices for Americans while getting other countries to pay more.”
“This represents the greatest victory for patient affordability in the history of American health care, by far, and every single American will benefit,” he added.
Several pharmaceutical executives stood behind the president during the announcement, including Sanofi CEO Paul Hudson, Novartis CEO Vas Narasimhan, Genentech CEO Ashley Magargee, Boehringer Ingelheim (USA) CEO Jean-Michel Boers, Gilead Sciences CEO Dan O’Day, Bristol Myers Squibb General Counsel Cari Gallman, GSK CEO Emma Walmsley, Merck CEO Robert Davis, and Amgen Executive Vice President Peter Griffith.
Also in attendance were Health and Human Services Secretary Robert F. Kennedy Jr., Commerce Secretary Howard Lutnick, Centers for Medicare and Medicaid Services Administrator Mehmet Oz, and Food and Drug Administration Commissioner Marty Makary.
Under the Trump Rx plan, the administration outlined a series of proposed drug price changes across multiple companies and therapeutic areas. Among them were reductions for Amgen’s cholesterol-lowering drug repatha from $573 to $239; Bristol Myers Squibb’s HIV medication reyataz from $1,449 to $217; Boehringer Ingelheim’s type 2 diabetes medication jentadueto from $525 to $55; Genentech’s flu medication xofluza from $168 to $50; and Gilead Sciences’ hepatitis C medication epclusa from $24,920 to $2,425.
Additional reductions included several GSK inhalers — such as the asthma inhaler advair diskus 500/50, from $265 to $89 — Merck’s diabetes medication januvia from $330 to $100, Novartis’ multiple sclerosis medication mayzent from $9,987 to $1,137, and Sanofi’s blood thinner plavix from $756 to $16. Sanofi insulin products would also be capped at $35 per month’s supply.
These prices, however, would only be available to patients who purchase medications directly through TrumpRx. According to the program’s website, TrumpRx “connects patients directly with the best prices, increasing transparency, and cutting out costly third-party markups.”
Kennedy spoke after Trump, thanking the president for efforts to lower pharmaceutical costs in the U.S., where evidence has shown that drug prices — including both brand-name and generic medications — are nearly 2.78 times higher than prices in comparable countries. According to the Pharmaceutical Research and Manufacturers of America, roughly half of every dollar spent on brand-name drugs goes to entities that play no role in their research, development, or manufacturing.
“This is affordability in action,” Kennedy said. “We are reversing that trend and making sure that Americans can afford to get the life-saving solutions.”
Gilead CEO Dan O’Day also spoke about how the restructuring of drug costs under TrumpRx, combined with emerging technologies, could help reduce HIV transmission — a virus that, if untreated, can progress to AIDS. The LGBTQ community remains disproportionately affected by HIV.
“Thank you, Mr. President — you and the administration,” O’Day said. “I think this objective of achieving the commitment to affordability and future innovation is extraordinary … We just recently launched a new medicine that’s only given twice a year to prevent HIV, and we’re working with Secretary Kennedy and his entire team, as well as the State Department, as a part of your strategy to support ending the epidemic during your term.
“I’ve never been more optimistic about the innovation that exists across these companies and the impact this could have on America’s health and economy,” he added.
Trump interjected, asking, “And that’s working well with HIV?”
“Yes,” O’Day replied.
“It’s a big event,” Trump said.
“It literally prevents HIV almost 100 percent given twice a year,” O’Day responded.
A similar anti-HIV medication is currently prescribed more than injectable form mentioned by O’Day. PrEP, is a medication regimen proven to significantly reduce HIV infection rates for people at high risk. Without insurance, brand-name Truvada can cost roughly $2,000 per month, while a generic version costs about $60 per month.
Even when medication prices are reduced, PrEP access carries additional costs, including clinic and laboratory fees, office visits, required HIV and sexually transmitted infection testing, adherence services and counseling, and outreach to potentially eligible patients and providers.
According to a 2022 study, the annual total cost per person for PrEP — including medication and required clinical and laboratory monitoring — is approximately $12,000 to $13,000 per year.
The TrumpRx federal platform website is now live at TrumpRx.gov, but the program is not slated to begin offering reduced drug prices until January.
The White House
EXCLUSIVE: Democracy Forward files FOIA lawsuit after HHS deadnames Rachel Levine
Trans former assistant health secretary’s name changed on official portrait
Democracy Forward, a national legal organization that works to advance democracy and social progress through litigation, policy and public education, and regulatory engagement, filed a lawsuit Friday in federal court seeking to compel the U.S. Department of Health and Human Services to release information related to the alteration of former Assistant Secretary for Health Adm. Rachel Levine’s official portrait caption.
The lawsuit comes in response to the slow pace of HHS’s handling of multiple Freedom of Information Act requests — requests that federal law requires agencies to respond to within 20 working days. While responses can take longer due to backlogs, high request volumes, or the need for extensive searches or consultations, Democracy Forward says HHS has failed to provide any substantive response.
Democracy Forward’s four unanswered FOIA requests, and the subsequent lawsuit against HHS, come days after someone in the Trump-Vance administration changed Levine’s official portrait in the Hubert H. Humphrey Building to display her deadname — the name she used before transitioning and has not used since 2011.
According to Democracy Forward, HHS “refused to release any records related to its morally wrong and offensive effort to alter former Assistant Secretary for Health Admiral Rachel Levine’s official portrait caption.” Levine was the highest-ranking openly transgender government official in U.S. history and served as assistant secretary for health and as an admiral in the U.S. Public Health Service Commissioned Corps from 2021 to 2025.
Democracy Forward President Skye Perryman spoke about the need to hold the Trump-Vance administration accountable for every official action, especially those that harm some of the most targeted Americans, including trans people.
“The question every American should be asking remains: what is the Trump-Vance administration hiding? For an administration that touts its anti-transgender animus and behavior so publicly, its stonewalling and silence when it comes to the people’s right to see public records about who was behind this decision is deafening,” Perryman said.
“The government’s obligation of transparency doesn’t disappear because the information sought relates to a trailblazing former federal official who is transgender. It’s not complicated — the public is entitled to know who is making decisions — especially decisions that seek to alter facts and reality, erase the identity of a person, and affect the nation’s commitment to civil rights and human dignity.”
“HHS’s refusal to respond to these lawful requests raises more serious concerns about transparency and accountability,” Perryman added. “The public has every right to demand answers — to know who is behind this hateful act — and we are going to court to get them.”
The lawsuit also raises questions about whether the alteration violated federal accuracy and privacy requirements governing Levine’s name, and whether the agency improperly classified the change as an “excepted activity” during a lapse in appropriations. By failing to make any determination or produce any records, Democracy Forward argues, HHS has violated its obligations under federal law.
The case, Democracy Forward Foundation v. U.S. Department of Health and Human Services, was filed in the U.S. District Court for the District of Columbia. The legal team includes Anisha Hindocha, Daniel McGrath, and Robin Thurston.
The Washington Blade reached out to HHS, but has not received any comment.
The lawsuit and four FOIA requests are below:
Your guide to D.C.’s queer New Year’s Eve parties
Long-awaited ‘Pillion’ surpasses the sexy buzz
Trump’s ‘American people derangement syndrome’
Reasons to be optimistic about 2026
Using movement to boost your mental health during holidays
Reasons to be optimistic about 2026
America is going in the wrong direction for intersex children
Rush reopens after renewing suspended liquor license
Long-awaited ‘Pillion’ surpasses the sexy buzz
